1-3 of 3
Jeffrey A. Barnes, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Does Not Improve Progression Free (PFS) or Overall Survival (OS) in Patients with Limited Stage Diffuse Large B Cell Lymphoma (DLBCL).

Ephraim P. Hochberg, MD, Nicole Birrer, Christiana E. Toomey, Jeffrey A. Barnes, M.D., Alfred Ian Lee, MD, Ann LaCasce, MD, Jeremy S. Abramson, MD
Journal: Blood
Blood (2009) 114 (22): 3755.
https://doi.org/10.1182/blood.V114.22.3755.3755
Published: 2009
Journal Articles

Rituximab Added to CODOX-M/IVAC Is Highly Effective in HIV-Negative and hiv-Positive Burkitt Lymphoma

Jeremy S. Abramson, MD, Jeffrey A. Barnes, M.D., Christiana E. Toomey, Eric D. Jacobsen, MD, Philippe Armand, Tak Takvorian, MD, David C. Fisher, MD, Hazel Reynolds, Ephraim P. Hochberg, Ann S. LaCasce, MD
Journal: Blood
Blood (2008) 112 (11): 3595.
https://doi.org/10.1182/blood.V112.11.3595.3595
Published: 2008
Journal Articles

Early Interim FDG-PET Scan Predicts Outcome in Non-Bulky Limited Stage Hodgkin Lymphoma, but may Not Guide Use of Consolidative Radiotherapy.

Jeffrey A. Barnes, M.D., Ann S. LaCasce, MD, Christiana E. Toomey, Ephraim Hochberg, Alfred I. Lee, George P. Canellos, MD, Jeremy S. Abramson, MD
Journal: Blood
Blood (2008) 112 (11): 1453.
https://doi.org/10.1182/blood.V112.11.1453.1453
Published: 2008